We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Videos

Video

Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis

In this talk, Martin Gijs discusses a novel magnetic surface coverage assay and a microfluidic tissue processor with applications in cancer diagnostics.
Video

Detection and Expression Profiling of Tumor Initiating Cells (TIC) Among the Peripherally Circulating Epithelial Tumor Cells from Patients with Breast Cancer

Katharina Pachmann shows that among the peripherally circulating tumor cells a variable fraction is able to express stem cell and adhesion properties and can be grown into tumor spheres, a property ascribed to cells capable of initiating tumors and metastases.
Video

Monitoring Dynamic Interactions of Tumor Cells with Tissue and Immune Cells in a Lab-on-a-Chip

Peter Ertl discusses how for the first time, direct cell-to-cell interactions of tumor cells with bead-activated primary T cells were continuously assessed using an effector cell to target cell ratio of 10:1.
Video

Improvements in Molecular Diagnosis of Pathogens and Diseases

This talk offers a valuable guide to the development of LAMP in molecular detection and determination of target sequences and will present examples with bright field applications of the method from the detection of pathogens to clinical applications for the diagnosis of cancer and other disorders.
Video

DNA Methylation and the Cancer Epigenome Biological and Translations Implications

In this talk, Stephen Baylin, discusses the development of strategies for “epigenetic therapies” for cancer and biomarker development.
Video

The Isolation and Characterization of Brain Metastasis – Competent Breast Cancer CTCs

Dario Marchetti, Professor/Director, Baylor College of Medicine, speaking at CellTech 2013.
Video

Regulation of antibody immunotherapy by fine-tuning FcR interactions

In this talk, Mark Cragg, presents evidence that different mAb's interact with Fc receptors differently in order to achieve their therapeutic activities.
Advertisement